Questions? Call 888-624-8373

PAPERBACK
list:$15.00
Web:$13.50
add to cart

Rights & Permissions

Free PDF Access
topleft topright

Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office (2008)
Board on Population Health and Public Health Practice (BPH)

Page
I
bottomleft bottomright
  E-mail
 Facebook
 Digg
 Stumble
 Twitter
More

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office

Initial Guidance for an Update of the National Vaccine Plan

A Letter Report to the National Vaccine Program Office

Committee on the Review of Priorities in the National Vaccine Plan

Board on Population Health and Public Health Practice

INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS

Washington, D.C.
www.nap.edu

 Page
I

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R1
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Initial Guidance for an Update of the National Vaccine Plan A Letter Report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan Board on Population Health and Public Health Practice INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES THE NATIONAL ACADEMIES PRESS Washington, D.C. www.nap.edu

OCR for page R2
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This study was supported by Contract No. HHSP23320042509XI, TO #15 between the National Academy of Sciences and the Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. Additional copies of this report are available from the National Academies Press, 500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu. For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu. Copyright 2008 by the National Academy of Sciences. All rights reserved. Printed in the United States of America The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin. Suggested citation: IOM (Institute of Medicine). 2008. Initial guidance for an update of the national vaccine plan: A letter report to the national vaccine program office. Washington, DC: The National Academies Press.

OCR for page R3
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office “Knowing is not enough; we must apply. Willing is not enough; we must do.” —Goethe INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES Advising the Nation. Improving Health.

OCR for page R4
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office THE NATIONAL ACADEMIES Advisers to the Nation on Science, Engineering, and Medicine The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine. The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council. www.national-academies.org

OCR for page R5
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office COMMITTEE ON THE REVIEW OF PRIORITIES IN THE NATIONAL VACCINE PLAN CLAIRE V. BROOME (Chair), Adjunct Professor, Division of Global Health, Rollins School of Public Health, Emory University ÈLAINE CHATIGNY, Director General of Communications, Public Health Agency of Canada TIMOTHY J. HOFF, Associate Professor of Health Policy and Management, Department of Health Policy, Management and Behavior, University at Albany, State University of New York GRACE M. LEE, Assistant Professor of Pediatrics, Children’s Hospital, Harvard University School of Medicine RICHARD MANDSAGER, Executive Director, The Children’s Hospital at Providence, Anchorage, Alaska EDGAR K. MARCUSE, Professor of Pediatrics, Children’s Hospital and Regional Medical Center, University of Washington School of Medicine A. DAVID PALTIEL, Professor and Acting Head, Division of Health Policy and Administration, Yale School of Public Health, Yale University ARTHUR REINGOLD, Professor and Head, Division of Epidemiology, School of Public Health, University of California, Berkeley DAVID B. REUBEN, Chief, Geriatric Medicine, and Director, Multicampus Program in Geriatric Medicine and Gerontology, University of California, Los Angeles SARA ROSENBAUM, Hirsh Professor and Chair, Department of Health Policy, The George Washington University School of Public Health and Health Services MILAGRITOS D. TAPIA, Assistant Professor, Pediatric Infectious Diseases, University of Maryland Study Staff ALINA BACIU, Study Director AMY GELLER, Senior Health Policy Associate LOUISE JORDAN, Senior Project Assistant ROSE MARIE MARTINEZ, Director, Board on Population Health and Public Health Practice

OCR for page R6
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office This page intentionally left blank.

OCR for page R7
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office REVIEWERS This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this report: Jo Ivey Boufford, New York Academy of Medicine Julie S. Downs, Department of Social and Decision Science, Carnegie Mellon University Barton F. Haynes, Duke Human Vaccine Institute Lisa Jackson, Group Health Center for Health Studies Samuel L. Katz, Department of Pediatrics, Duke University Medical Center Adel A.F. Mahmoud, Woodrow Wilson School and Department of Molecular Biology Princeton University Joshua P. Metlay, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Thomas W. Valente, Department of Preventive Medicine, Keck School of Medicine, University of Southern California Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the conclusions or recommendations nor did they see the final draft of the report before its release. The review of this report was overseen by Floyd E. Bloom, The Scripps Research Institute. Appointed by the National Research Council, he was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the authoring committee and the institution.

OCR for page R8
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office This page intentionally left blank.

OCR for page R9
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office CONTENTS      BACKGROUND   1      Features of the 1994 National Vaccine Plan,   3      The Committee’s Approach to Reviewing the Plan,   3      CHANGES SINCE 1994   3      PROGRESS SINCE 1994   4      GUIDANCE FOR DEVELOPING A NEW NATIONAL VACCINE PLAN   8      Process Issues,   8      Content Areas,   13      CONCLUDING REMARKS   17     APPENDIXES     A   References   19 B   Statement of Task   22 C   Meeting One Agenda   23 D   1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes   26

OCR for page R10
Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office This page intentionally left blank.